Global Myelodysplastic Syndrome (MDS) Treatment Drugs Market Is Expanding At CAGR Of 9.5% From 2017 To 2025 - Credence Research
Browse the full report Myelodysplastic Syndrome (MDS) Treatment Drugs Market - Growth, Future Prospects and Competitive Analysis, 2017 – 2025 report at http://www.credenceresearch.com/report/myelodysplastic-syndrome-msds-treatment-drugs-market
Myelodysplastic syndrome (MDS) is group of blood and bone marrow disorders. It is form of cancer involving production of abnormal and immature blood cells. The global myelodysplastic syndrome (MDS) treatment drugs market is segmented on the basis of drug classes such as hypomethylating agents, immunomodulatory drugs, growth factors and others. Currently, the demand for hypomethylating agent is the highest in market as these are preferably used as targeted therapy in low and high risk MDS patients due to its efficacy. Only 3 drugs are presently approved by the US-FDA for the treatment of MDS are Azacitidine, Decitabine, Lenalidomide. Since 2006, no drug has been approved in the United States exclusive for the treatment of MDS. Therefore, expected launch of ideal pipeline drugs such as JNJ-63935937, MLN-4924, NSC 39069 and rigosertib would assist in significant market growth during forecast period.
In the year 2016, North America leads the global MDS treatment drugs market as a result of increase in number of patients suffering with MDS, early adoption of novel medications, high investments in R&D and greater spending in the healthcare systems. However, Asia Pacific reflects significant market opportunities due to developing healthcare infrastructure, rapidly improving economic conditions, and welcoming regulatory environment for new drugs.
Market Competition Assessment:
In the recent years only three drugs (Azacitidine, Decitabine and Lenalidomide) are approved by the FDA for treatment of MDS. However, due to the strong presence of pipeline molecules MDS treatment drugs market experience a shift. Some players such as Celator Pharmaceuticals (Jazz Pharmaceuticals plc.), Bayer AG, Celgene Corporation, Cell Therapeutics, Inc., Daiichi Sankyo Company, Ltd., Incyte Corporation, Janssen Biotech, Inc., MedImmune, LLC (AstraZeneca), Millennium Pharmaceuticals (Takeda Pharmaceutical), Novartis AG, Onconova Therapeutics, Inc., Pfizer, Inc., and Taiho Pharmaceutical (Otsuka Holdings) enjoy prominence in the global MDS treatment drugs market.
Key Market Movements:
Key factors such as strong presence of ideal pipeline molecules, higher number of unmet needs and growing incidence of MDS are key factors would assist the growth of MDS treatment drugs market over the forecast period.
Expected approval to three major pipeline drugs within the forecast period
To Get Complete Report @ http://www.credenceresearch.com/report/myelodysplastic-syndrome-msds-treatment-drugs-market
Browse All Reports of This Category :- http://www.credenceresearch.com/industry/pharmaceuticals-market
Blog : http://www.mobilecomputingtoday.co.uk/7346/myelodysplastic-syndrome-mds-treatment-drugs-market-expanding-cagr-9-5-2017-2025-credence-research/
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Name: Chris Smith
Designation: Global Sales Manager
This release was published on openPR.
Permanent link to this press release:
You can edit or delete your press release Global Myelodysplastic Syndrome (MDS) Treatment Drugs Market Is Expanding At CAGR Of 9.5% From 2017 To 2025 - Credence Research here
News-ID: 949229 • Views: 215
More Releases from Credence Research Inc
ePrison Market is gaining huge growth |Market valued at US$ 1.81 Bn in 2018
The global ePrison market was valued at US$ 1.81 Bn in 2018 and is expected to expand at a CAGR of 6.2% during the forecast from 2019 to 2027. Market Insight ePrison solutions help administrators of correctional homes & prisons to get real-time access to information about staff and prison inmates, thereby helping to ensure discipline, safety, and gauge the needs of inmates. The use of these solutions is not only limited
Cochlear Implants Market - Growth, Future Prospects & Competitive Analysis, 2018 …
Cochlear Implants– Global Market Size, Analysis, Share, Trends, Growth and Forecast to 2026 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). The report firstly introduced the Cochlear Implants: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures and
Marine Internet Of Things (IoT) Market Growth, Future Prospects & Competitive An …
Marine Internet Of Things (IoT)– Global Market Size, Analysis, Share, Trends, Growth and Forecast to 2026 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). The report firstly introduced the Marine Internet Of Things (IoT): definitions, classifications, applications and market overview; product
Laundry Care Market : Key Trends with Market size, Industry Share, Market player …
Credence Research lately added a new report titled "Laundry Care Market - Industry Size, Global Trends, Growth, Opportunities, Market Share and Market Forecast - 2018 to 2026" to its repository. This latest research study investigates the Laundry Care market through different segments primarily based on type, application and end-use, market participants, areas and presents country-level evaluation over the forecast period from 2018 to 2026. Browse Here For Full Report with ToC:
More Releases for MDS
Healthcare M2M Market to See Huge Growth by 2025 | Athenahealth, McKesson, Amazi …
The Latest research study released by HTF MI “Global Healthcare M2M Market” with 100+ pages of analysis on business Strategy taken up by key and emerging industry players and delivers know how of the current market development, landscape, technologies, drivers, opportunities, market viewpoint and status. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Some of the Major Companies covered in this Research
Myeloidysplastic Syndromes (MDS) – Epidemiology Insights (2016-2028)
Myeloidysplastic syndromes (MDS) can be described as a group of hematologic malignancies, that occurr due to abnormality in blood-forming cells in the bone marrow. It is a rare blood cancer and can be mild, moderate or severe, in terms of severity. Download the sample report @ https://www.pharmaproff.com/request-sample/1162 This syndrome can be classified into three main types: MDS with single lineage dysplasia wherein a single type of blood cell appears abnormal; multilineage
Top Scenario: Healthcare CRM Market By Key Players: Allscripts, Cerner, e-MDs, C …
Qyresearchreports include new market research report Healthcare CRM to its huge collection of research reports. Healthcare CRM, also known as Healthcare Relationship Management, is a broadly used term for a Customer relationship management system In 2017, the global Healthcare CRM market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025. This report focuses on the global
Myelodysplastic Syndrome (MDS) Treatment Market Industry Forecast till 2025
Myelodysplastic (MDS) syndrome is a type of bone marrow disorder, where bone marrow is unable to produce healthy and mature blood cells. The immature blood cells called as blasts, get stored in the bone marrow and blood and obstruct the natural function of the hematological system which results in depletion of healthy red blood cells, platelets, and white blood cells. Myelodysplastic syndrome is usually seen in geriatric population and more
Global Myelodysplastic Syndrome (MDS) Therapeutics Market Size, Trends, Analysis …
An up-to-date research report has been disclosed by Market Research Hub highlighting the title “2018-2025 Report on Global and United States Myelodysplastic Syndrome (MDS) Therapeutics Market Status and Forecast, by Players, Types and Applications” which provides an outlook of current market growth as well as the expected forecast including Rate on Investment (ROI) together with growing CAGR near XX% during 2018-2025. The report studies myelodysplastic syndrome therapeutics in global market,
Myelodysplastic Syndrome (MDS) Treatment Market - Global Industry Insights 2025
Myelodysplastic syndrome (MDS) is a disorder, which affects the bone marrow and produces immature blood cells. Bone marrow failure leads to lowering the levels of healthy blood cells circulation in the bloodstream. According to Seattle Cancer Care Alliance, around 80%-85% of people with MDS have more cells in their bone marrow than healthy people. According to National Organization for Rare Disorders, MDS deteriorates into a form of cancer in around